Return to search

NodThera attracts $55m

UK and U.S.-based NodThera, a developer of medicines that treat diseases driven by chronic inflammation, has raised $55 million in funding.

UK and U.S.-based NodThera, a developer of medicines that treat diseases driven by chronic inflammation, has raised $55 million in funding. Novo Ventures, part of Novo Holdings, led the round. In addition to the funding, Nanna Lüneborg, a partner at Novo Ventures, will join the NodThera board.

Source: Press Release